Journal Publishes Pivotal Data Demonstrating Efficacy and Safety of ELOCTATE for Hemophilia A
November 13, 2013 at 10:11 AM EST
Today Biogen Idec (NASDAQ: BIIB ) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) announced that the detailed phase 3 data for the companies' investigational long-lasting